Hyperandrogenic women treated with a continuous-regimen oral contraceptive
Authors:
- Salvatore CarusoSCSalvatore Caruso
- Stefano CianciSCStefano Cianci
- Chiara MalandrinoCMChiara Malandrino
- Carla CiceroCCCarla Cicero
- Lucia Lo PrestiLPLucia Lo Presti
- Antonio CianciACAntonio Cianci
- 1 December 2013
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 171 (2) , 307-310
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Preliminary Study on the Effect of Four-phasic Estradiol Valerate and Dienogest (E2V/DNG) Oral Contraceptive on the Quality of Sexual LifeThe Journal of Sexual Medicine, 2011
- Current issues and available options in combined hormonal contraceptionContraception, 2011
- The evolution of combined oral contraception: improving the risk-to-benefit ratioContraception, 2011
- Conventional vs. Extended-Cycle Oral Contraceptives on the Quality of Sexual Life: Comparison Between Two Regimens Containing 3 mg Drospirenone and 20 µg Ethinyl EstradiolThe Journal of Sexual Medicine, 2011
- Recent Innovations in Oral ContraceptionSeminars in Reproductive Medicine, 2010
- Quality of Sexual Life in Hyperandrogenic Women Treated with an Oral Contraceptive Containing Chlormadinone AcetateThe Journal of Sexual Medicine, 2009
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestationsGynecological Endocrinology, 2008
- Treatment of hirsutism and acne in hyperandrogenismBest Practice & Research Clinical Endocrinology & Metabolism, 2006
- The role of combined oral contraceptives in the management of acne and seborrheaThe European Journal of Contraception & Reproductive Health Care, 2004
- Assessment and management of anovulatory infertility in polycystic ovary syndromeEndocrinology and Metabolism Clinics of North America, 2003